Triathlon Tritanium Knee Outcomes Study
Terminated · Not applicable · NCT02155712
Conditions: Arthroplasty, Replacement, Knee
At a glance
- Research payments reported, 2025
- $1,358
- U.S. investigators named
- 1
- Sites paid
- 1
- Planned or actual enrollment
- 680
About the trial
- Sponsor
- Stryker Orthopaedics
- Tested
- Triathlon Tritanium Knee (device), Triathlon Knee (device)
- Dates
- Started 2014-10; completion 2023-03-11
- Results posted
- Yes
The success of the Triathlon Tritanium Knee will be determined by comparing the rate of absence of revision for aseptic loosening of the tibial baseplate at 2 years with the rates reported in the literature.
From ClinicalTrials.gov, last updated 2023-11-14. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Stryker Corporation reported $1,358 in research payments for this study in 2025 (2 payments).
Products named: Triathlon, Tritanium
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.